Bad News for Device Sponsors: Panel Meetings were Already Going the Way of the Homework Assignment, and COVID Might “Put the Nail in the Coffin”
Update Magazine | Fall 2020
Keeping Track of the Quacks: Drug and Device Enforcement in the COVID-19 Era
Update Magazine | Fall 2020
Lessons from Recent Medical Device Criminal Resolutions
Update Magazine | Fall 2020
How Will FDA Regulate Disease-Sniffing Dogs?
Update Magazine | Fall 2020
FDLJ Symposium Spotlight: Development and Regulation of Innovations: In the Current State of Facts vs. Public Opinions, the Truth Does Not Always Prevail GalleryFDLJ Symposium Spotlight: Development and Regulation of Innovations: In the Current State of Facts vs. Public Opinions, the Truth Does Not Always Prevail
FDLJ Symposium Spotlight: Development and Regulation of Innovations: In the Current State of Facts vs. Public Opinions, the Truth Does Not Always Prevail
Update Magazine | Summer 2020
COVID-19 Response Focuses Renewed Interest in FDA’s Stance on Donations of FDA-Regulated Products
Update Magazine | Summer 2020
OTC Monograph Reform Legislation is Now Law—What Does It Do?
Update Magazine | Summer 2020
The Impact of DOJ’s Evaluation of Corporate Compliance Programs on FDA-Regulated Products
Update Magazine | Summer 2020
More Foreign Drug Companies Registering Drug Master Files in China
Update Magazine | Summer 2020
A Cannabidiol Catalyst? Recent Events Increase Pressure on FDA to Regulate CBD
Update Magazine | Spring 2020
